Robert Strausberg has been named deputy director of the J. Craig Venter Institute as part of a broad reorganization of its two research divisions — the Institute for Genomic Research and the Center for the Advancement of Genomics — into several more tightly focused units.
The JCVI will now consist of 10 distinct research groups: Genomic Medicine, Infectious Disease, Synthetic Biology & Bioenergy, Plant Genomics, Microbial & Environmental Genomics, Pathogen Functional Genomics, Applied Bioinformatics, Research Informatics, Software Engineering, and a Policy Center.
Craig Venter will remain president and chairman of the institute, and Strausberg, who had been president of TCAG, has been named deputy director. Eric Eisenstadt, former vice president for research of TIGR, has been named deputy vice president for research.
Marv Frazier, former vice president for research at TCAG, is now the executive vice president for research. Julie Gross Adelson has been named general counsel, while Aimee Turner, formerly CFO at TIGR, is now CFO of the JCVI.
Gene Logic has elected David Urdal and Mark Gabrielson to its board of directors.
Urdal is currently senior vice president and chief scientific officer of Dendreon, while Gabrielson is a co-founder, director, and CEO of Pulmatrix.
In addition, the company said that Jules Blake is retiring from the board of directors after serving on the board since 1994.
IO Informatics has tapped Robert Stanley as president and CEO. Stanley is a company co-founder and was formerly chief technology officer at IO Informatics.
Stanley replaces former CEO Patricia Rougeau, who left the firm at the end of March.